Development and validation of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs

Recruiting

• Conditions: Patients with oral anticancer drugs, regardless of the exact type of cancer; C00-C97; Malignant neoplasms

• Registration Number: DRKS00034341
• Lead Sponsor: Pharmazeutisches Institut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

ICD-10 C diagnosis
- Oral anticancer therapy
- Medication self-administration
- Written consent to participate in the study

Exclusion Criteria

- Off-label therapy
- Lack of German language skills
- Other conditions or diseases that impair understanding of the questionnaire (e.g. dementia)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs

Secondary Outcome Measures

Name	Time	Method
Evaluation of the validity of the questionnaire using univariate and multivariate regression analyses